than for spina bifida is to be expected as anencephaly is easier to diagnose by ultrasonography and it is usually associated with a high matemal serum a fetoprotein concentration. Serum a fetoprotein concentration is not often raised in closed spina bifida (which comprised 24-6% of the spina bifida cases in 1986-91). The fall in birth prevalence and the proportion of defects detected prenatally are consistent with the findings of other centres with a population based maternal serum a fetoprotein screening programme and wide access to ultrasound screening in pregnancy.2 10 Centres without a population based serum a fetoprotein screening programme have generally achieved a lower proportion ofprenatal diagnoses.2 9 The impact of prenatal diagnosis on birth prevalence is dependent not only on the sensitivity of the screening programme but also on the uptake of testing by doctors and pregnant women, presentation for antenatal care in time for screening and legal termination of pregnancy, and the attitude to termination of pregnancy ofcouples with affected fetuses.
Our results show the value of population based registers in accurate ascertainment of birth defects, which enables assessment of the effect of preventive strategies. The centralised maternal serum a fetoprotein screening programme facilitated ascertainment. Folate has been shown to reduce the rate of neural tube defects when taken before conception and in the early months of pregnancy. '9 20 There is no formal policy on the use of folate before conception in South Australia, but the Australian National Health and Medical Research Council has recommended that women who have had an affected pregnancy or have a family history of neural tube defect should be offered genetic counselling and folic acid supplements around the time of conception (5 mg daily). The council has also recently recommended (115th session, Adelaide, June 1993) that women in low risk groups should take 0 5 mg of folic acid daily around the time of conception, that all women of childbearing age should be encouraged to increase their intake of folate rich foods, and that staple foods should be fortified with folic acid.
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